Barbara Pala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Barbara Pala has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Antonino De Lorenzo
Section of Food Science, Clinical Nutrition and Pharmaceutical Sciences, Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy
2 shared publications- Francesco Cribari
UOC Cardiologia Ospedale IDI- IRCCS, Rome, Italy
2 shared publications Gianluca Iacobellis
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Iacobellis Gianluca, University of Miami, Leonard M. Miller School of Medicine, Miami, USA
2 shared publications- Laura Di Renzo
Section of Food Science, Clinical Nutrition and Pharmaceutical Sciences, Department of Biomedicine and Prevention, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy
2 shared publications - Luigi Barrea
Dipartimento di Psicologia e Scienze della Salute, Università Telematica Pegaso, Naples, Italy
2 shared publications - Marco Alfonso Perrone
Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy
2 shared publications
Latest Publications
- Open Access
- 10 October 2026
- Published by Springer Nature in Current Obesity Reports
- Vol. 15 (1) , 90
Correction to: The Role of Echocardiography in the Assessment of Epicardial Adipose Tissue: A Systematic Review and Meta-analysis
- 10 October 2026
- Published by Springer Nature in Current Obesity Reports
- Vol. 15 (1) , 90
Open AccessCorrection to: The Role of Echocardiography in the Assessment of Epicardial Adipose Tissue: A Systematic Review and Meta-analysis
- Open Access
- 23 July 2026
- Published by Springer Nature in Current Obesity Reports
- Vol. 15 (1) , 63
The Role of Echocardiography in the Assessment of Epicardial Adipose Tissue: A Systematic Review and Meta-analysis
Background: Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot implicated in cardiometabolic and cardiovascular (CV) disease. Although cardiac magnetic resonance (CMR) and cardiac computed tomography (cCT) enable accurate volumetric quantification of EAT, their cost, limited availability, and—particularly for cCT—radiation exposure, restrict their use in preventive and longitudinal settings. Transthoracic echocardiography (TTE) is widely accessible and radiation-free, but its validity as a surrogate of volumetric EAT assessment and its broader clinical role remain incompletely defined. Objectives: To systematically synthesize disease-specific evidence linking TTE-derived EAT thickness with major CV phenotypes and to quantitatively assess its association with volumetric EAT measured by CMR or cCT. Methods: A systematic search of PubMed and PubMed Central (January 2000–December 2025) identified adult studies evaluating associations between TTE-derived EAT thickness and coronary artery disease (CAD), atrial fibrillation (AF), or heart failure with preserved ejection fraction (HFpEF), and correlations between TTE-derived EAT thickness and CMR- or cCT-derived EAT volume. Correlation coefficients were pooled using a random-effects model after Fisher’s z-transformation. An exploratory meta-analysis assessed associations with major adverse cardiovascular events (MACE). Results: Seventeen disease-specific studies consistently demonstrated associations between increased TTE-derived EAT thickness and CAD severity, AF burden and recurrence, and adverse HFpEF phenotypes. Five validation studies were included; four comparing TTE with CMR were pooled, yielding a moderate-to-strong correlation ( r = 0.77, 95% CI 0.65–0.93; p < 0.01; I² = 92.9%). Several studies reported associations between TTE- EAT thickness and cCT-derived EAT parameters. However, only one cCT study met our predefined criteria for inclusion in the quantitative validation analysis, whereas the remaining cCT studies were retained in the qualitative synthesis because of substantial methodological heterogeneity in cCT acquisition, segmentation approaches, and outcome definitions. Exploratory prognostic analysis suggested a directional association between increased TTE-derived EAT thickness and MACE. Conclusions: TTE-derived EAT thickness correlates with volumetric EAT and is consistently associated with major CV phenotypes. Standardization and prospective outcome-driven validation are required before routine clinical implementation.
- 23 July 2026
- Published by Springer Nature in Current Obesity Reports
- Vol. 15 (1) , 63
Open AccessThe Role of Echocardiography in the Assessment of Epicardial Adipose Tissue: A Systematic Review and Meta-analysis
Background: Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot implicated in cardiometabolic and cardiovascular (CV) disease. Although cardiac magnetic resonance (CMR) and cardiac computed tomography (cCT) enable accurate volumetric quantification of EAT, their cost, limited availability, and—particularly for cCT—radiation exposure, restrict their use in preventive and longitudinal settings. Transthoracic echocardiography (TTE) is widely accessible and radiation-free, but its validity as a surrogate of volumetric EAT assessment and its broader clinical role remain incompletely defined. Objectives: To systematically synthesize disease-specific evidence linking TTE-derived EAT thickness with major CV phenotypes and to quantitatively assess its association with volumetric EAT measured by CMR or cCT. Methods: A systematic search of PubMed and PubMed Central (January 2000–December 2025) identified adult studies evaluating associations between TTE-derived EAT thickness and coronary artery disease (CAD), atrial fibrillation (AF), or heart failure with preserved ejection fraction (HFpEF), and correlations between TTE-derived EAT thickness and CMR- or cCT-derived EAT volume. Correlation coefficients were pooled using a random-effects model after Fisher’s z-transformation. An exploratory meta-analysis assessed associations with major adverse cardiovascular events (MACE). Results: Seventeen disease-specific studies consistently demonstrated associations between increased TTE-derived EAT thickness and CAD severity, AF burden and recurrence, and adverse HFpEF phenotypes. Five validation studies were included; four comparing TTE with CMR were pooled, yielding a moderate-to-strong correlation ( r = 0.77, 95% CI 0.65–0.93; p < 0.01; I² = 92.9%). Several studies reported associations between TTE- EAT thickness and cCT-derived EAT parameters. However, only one cCT study met our predefined criteria for inclusion in the quantitative validation analysis, whereas the remaining cCT studies were retained in the qualitative synthesis because of substantial methodological heterogeneity in cCT acquisition, segmentation approaches, and outcome definitions. Exploratory prognostic analysis suggested a directional association between increased TTE-derived EAT thickness and MACE. Conclusions: TTE-derived EAT thickness correlates with volumetric EAT and is consistently associated with major CV phenotypes. Standardization and prospective outcome-driven validation are required before routine clinical implementation.